|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Zentalis Pharmaceuticals (NASDAQ: ZNTL) through any online brokerage.
The latest price target for Zentalis Pharmaceuticals (NASDAQ: ZNTL) was reported by UBS on May 21, 2021. The analyst firm set a price target for 91.00 expecting ZNTL to rise to within 12 months (a possible 74.93% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Zentalis Pharmaceuticals (NASDAQ: ZNTL) is $52.02 last updated Thu Jun 24 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Zentalis Pharmaceuticals.
There is no upcoming split for Zentalis Pharmaceuticals.
Zentalis Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.